Nebulized liposomal amphotericin B for treating Aspergillus empyema with bronchopleural fistula

Am J Respir Crit Care Med. 2014 Mar 1;189(5):607-8. doi: 10.1164/rccm.201311-2086LE.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Administration, Inhalation
  • Amphotericin B / administration & dosage*
  • Amphotericin B / therapeutic use
  • Antifungal Agents / administration & dosage*
  • Antifungal Agents / therapeutic use
  • Aspergillus fumigatus / isolation & purification*
  • Bronchial Fistula / microbiology*
  • Empyema / complications
  • Empyema / diagnosis
  • Empyema / drug therapy*
  • Humans
  • Male
  • Middle Aged
  • Pleural Diseases / microbiology*
  • Pulmonary Aspergillosis / complications
  • Pulmonary Aspergillosis / diagnosis
  • Pulmonary Aspergillosis / drug therapy*

Substances

  • Antifungal Agents
  • liposomal amphotericin B
  • Amphotericin B